Management of Status Epilepticus in Children

Douglas M Smith, Emily L McGinnis, Diana J Walleigh, Nicholas S Abend, Douglas M Smith, Emily L McGinnis, Diana J Walleigh, Nicholas S Abend

Abstract

Status epilepticus is a common pediatric neurological emergency. Management includes prompt administration of appropriately selected anti-seizure medications, identification and treatment of seizure precipitant(s), as well as identification and management of associated systemic complications. This review discusses the definitions, classification, epidemiology and management of status epilepticus and refractory status epilepticus in children.

Keywords: pediatric; seizure; status epilepticus.

References

    1. Chin R.F., Neville B.G., Peckham C., Bedford H., Wade A., Scott R.C. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: Prospective population-based study. Lancet. 2006;368:222–229. doi: 10.1016/S0140-6736(06)69043-0.
    1. Roger J., Lob H., Tassinari C.A. Status epilepticus. In: Magnus O., de Lorentz Haas A.M., editors. Handbook of Clinical Neurology: The Epilepsies. Volume 15. North Holland Publishing Company; Amsterdam, The Netherlands: 1974. pp. 145–188.
    1. Commission on epidemiology and prognosis, international league against epilepsy: Guidelines for epidemiologic studies on epilepsy. Epilepsia. 1993;34:592–596.
    1. Evans M., Griffiths T., Meldrum B. Early changes in the rat hippocampus following seizures induced by bicuculline or l-allylglycine: A light and electron microscope study. Neuropathol. Appl. Neurobiol. 1983;9:39–52. doi: 10.1111/j.1365-2990.1983.tb00322.x.
    1. Meldrum B.S., Vigouroux R.A., Brierley J.B. Systemic factors and epileptic brain damage. Prolonged seizures in paralyzed, artificially ventilated baboons. Arch. Neurol. 1973;29:82–87. doi: 10.1001/archneur.1973.00490260026003.
    1. DeLorenzo R.J., Garnett L.K., Towne A.R., Waterhouse E.J., Boggs J.G., Morton L., Choudhry M.A., Barnes T., Ko D. Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29 minutes. Epilepsia. 1999;40:164–169. doi: 10.1111/j.1528-1157.1999.tb02070.x.
    1. Trinka E., Cock H., Hesdorffer D., Rossetti A.O., Scheffer I.E., Shinnar S., Shorvon S., Lowenstein D.H. A definition and classification of status epilepticus—Report of the ilae task force on classification of status epilepticus. Epilepsia. 2015;56:1515–1523. doi: 10.1111/epi.13121.
    1. Brophy G.M., Bell R., Claassen J., Alldredge B., Bleck T.P., Glauser T., Laroche S.M., Riviello J.J., Jr., Shutter L., Sperling M.R., et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit. Care. 2012;17:3–23. doi: 10.1007/s12028-012-9695-z.
    1. Glauser T., Shinnar S., Gloss D., Alldredge B., Arya R., Bainbridge J., Bare M., Bleck T., Dodson W.E., Garrity L., et al. Evidence-based guideline: Treatment of convulsive status epilepticus in children and adults: Report of the guideline committee of the American epilepsy society. Epilepsy Curr. 2016;16:48–61. doi: 10.5698/1535-7597-16.1.48.
    1. Alford E.L., Wheless J.W., Phelps S.J. Treatment of generalized convulsive status epilepticus in pediatric patients. J. Pediatr. Pharmacol. Ther. 2015;20:260–289.
    1. Shinnar S., Berg A.T., Moshe S.L., Shinnar R. How long do new-onset seizures in children last? Ann. Neurol. 2001;49:659–664. doi: 10.1002/ana.1018.
    1. Chin R.F., Neville B.G., Peckham C., Wade A., Bedford H., Scott R.C. Treatment of community-onset, childhood convulsive status epilepticus: A prospective, population-based study. Lancet Neurol. 2008;7:696–703. doi: 10.1016/S1474-4422(08)70141-8.
    1. Lambrechtsen F.A., Buchhalter J.R. Aborted and refractory status epilepticus in children: A comparative analysis. Epilepsia. 2008;49:615–625. doi: 10.1111/j.1528-1167.2007.01465.x.
    1. Lewena S., Young S. When benzodiazepines fail: How effective is second line therapy for status epilepticus in children? Emerg. Med. Australas. 2006;18:45–50. doi: 10.1111/j.1742-6723.2006.00807.x.
    1. Eriksson K., Metsaranta P., Huhtala H., Auvinen A., Kuusela A.L., Koivikko M. Treatment delay and the risk of prolonged status epilepticus. Neurology. 2005;65:1316–1318. doi: 10.1212/01.wnl.0000180959.31355.92.
    1. Hayashi K., Osawa M., Aihara M., Izumi T., Ohtsuka Y., Haginoya K., Kato I., Kaneko K., Sugai K., Takahashi T., et al. Efficacy of intravenous midazolam for status epilepticus in childhood. Pediatr. Neurol. 2007;36:366–372. doi: 10.1016/j.pediatrneurol.2007.02.012.
    1. Sanchez Fernandez I., Abend N.S., Agadi S., An S., Arya R., Brenton J.N., Carpenter J.L., Chapman K.E., Gaillard W.D., Glauser T.A., et al. Time from convulsive status epilepticus onset to anticonvulsant administration in children. Neurology. 2015;84:2304–2311. doi: 10.1212/WNL.0000000000001673.
    1. Tobias J.D., Berkenbosch J.W. Management of status epilepticus in infants and children prior to pediatric ICU admission: Deviations from the current guidelines. South. Med. J. 2008;101:268–272. doi: 10.1097/SMJ.0b013e318164e3f0.
    1. Lewena S., Pennington V., Acworth J., Thornton S., Ngo P., McIntyre S., Krieser D., Neutze J., Speldewinde D. Emergency management of pediatric convulsive status epilepticus: A multicenter study of 542 patients. Pediatr. Emerg. Care. 2009;25:83–87. doi: 10.1097/PEC.0b013e318196ea6e.
    1. Shorvon S., Baulac M., Cross H., Trinka E., Walker M. The drug treatment of status epilepticus in Europe: Consensus document from a workshop at the first London colloquium on status epilepticus. Epilepsia. 2008;49:1277–1286.
    1. Abend N.S., Bearden D., Helbig I., McGuire J., Narula S., Panzer J.A., Topjian A., Dlugos D.J. Status epilepticus and refractory status epilepticus management. Semin. Pediatr. Neurol. 2014;21:263–274. doi: 10.1016/j.spen.2014.12.006.
    1. Abend N.S., Loddenkemper T. Management of pediatric status epilepticus. Curr. Treat. Options Neurol. 2014;16:1–16. doi: 10.1007/s11940-014-0301-x.
    1. Aicardi J., Chevrie J.J. Convulsive status epilepticus in infants and children. A study of 239 cases. Epilepsia. 1970;11:187–197. doi: 10.1111/j.1528-1157.1970.tb03880.x.
    1. DeLorenzo R.J., Hauser W.A., Towne A.R., Boggs J.G., Pellock J.M., Penberthy L., Garnett L., Fortner C.A., Ko D. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996;46:1029–1035. doi: 10.1212/WNL.46.4.1029.
    1. Hesdorffer D.C., Logroscino G., Cascino G., Annegers J.F., Hauser W.A. Incidence of status epilepticus In Rochester, Minnesota, 1965–1984. Neurology. 1998;50:735–741. doi: 10.1212/WNL.50.3.735.
    1. Wu Y.W., Shek D.W., Garcia P.A., Zhao S., Johnston S.C. Incidence and mortality of generalized convulsive status epilepticus in California. Neurology. 2002;58:1070–1076. doi: 10.1212/WNL.58.7.1070.
    1. Dham B.S., Hunter K., Rincon F. The epidemiology of status epilepticus in the United States. Neurocrit. Care. 2014;20:476–483. doi: 10.1007/s12028-013-9935-x.
    1. Maytal J., Shinnar S., Moshe S.L., Alvarez L.A. Low morbidity and mortality of status epilepticus in children. Pediatrics. 1989;83:323–331.
    1. Sillanpaa M., Shinnar S. Status epilepticus in a population-based cohort with childhood-onset epilepsy in Finland. Ann Neurol. 2002;52:303–310. doi: 10.1002/ana.10286.
    1. Madden L.K., DeVon H.A. A systematic review of the effects of body temperature on outcome after adult traumatic brain injury. J. Neurosci. Nurs. 2015;47:190–203. doi: 10.1097/JNN.0000000000000142.
    1. Koivunen R.J., Haapaniemi E., Satopaa J., Niemela M., Tatlisumak T., Putaala J. Medical acute complications of intracerebral hemorrhage in young adults. Stroke Res. Treat. 2015;2015 doi: 10.1155/2015/357696.
    1. Hussain N., Appleton R., Thorburn K. Aetiology, course and outcome of children admitted to paediatric intensive care with convulsive status epilepticus: A retrospective 5-year review. Seizure. 2007;16:305–312. doi: 10.1016/j.seizure.2007.01.007.
    1. Singh R.K., Stephens S., Berl M.M., Chang T., Brown K., Vezina L.G., Gaillard W.D. Prospective study of new-onset seizures presenting as status epilepticus in childhood. Neurology. 2010;74:636–642. doi: 10.1212/WNL.0b013e3181d0cca2.
    1. Nishiyama I., Ohtsuka Y., Tsuda T., Inoue H., Kunitomi T., Shiraga H., Kimura T., Fujimoto K. An epidemiological study of children with status epilepticus in Okayama, Japan. Epilepsia. 2007;48:1133–1137. doi: 10.1111/j.1528-1167.2007.01106.x.
    1. Riviello J.J., Ashwal S., Hirtz D., Glauser T., Ballaban-Gil K., Kelley K., Morton L.D., Phillips S., Sloan E., Shinnar S. Practice parameter: Diagnostic assessment of the child with status epilepticus (an evidence-based review) Neurology. 2006;67:1542–1550. doi: 10.1212/01.wnl.0000243197.05519.3d.
    1. Watemberg N., Segal G. A suggested approach to the etiologic evaluation of status epilepticus in children: What to seek after the usual causes have been ruled out. J. Child Neurol. 2010;25:203–211. doi: 10.1177/0883073809337032.
    1. Herman S.T., Abend N.S., Bleck T.P., Chapman K.E., Drislane F.W., Emerson R.G., Gerard E.E., Hahn C.D., Husain A.M., Kaplan P.W., et al. Consensus statement on continuous EEG in critically ill adults and children, part I: Indications. J. Clin. Neurophysiol. 2015;32:87–95. doi: 10.1097/WNP.0000000000000166.
    1. Herman S.T., Abend N.S., Bleck T.P., Chapman K.E., Drislane F.W., Emerson R.G., Gerard E.E., Hahn C.D., Husain A.M., Kaplan P.W., et al. Consensus statement on continuous EEG in critically ill adults and children, part II: Personnel, technical specifications, and clinical practice. J. Clin. Neurophysiol. 2015;32:96–108. doi: 10.1097/WNP.0000000000000165.
    1. Abend N.S., Arndt D.H., Carpenter J.L., Chapman K.E., Cornett K.M., Gallentine W.B., Giza C.C., Goldstein J.L., Hahn C.D., Lerner J.T., et al. Electrographic seizures in pediatric ICU patients: Cohort study of risk factors and mortality. Neurology. 2013;81:383–391. doi: 10.1212/WNL.0b013e31829c5cfe.
    1. Fernandez I.S., Abend N.S., Arndt D.H., Carpenter J.L., Chapman K.E., Cornett K.M., Dlugos D.J., Gallentine W.B., Giza C.C., Goldstein J.L., et al. Electrographic seizures after convulsive status epilepticus in children and young adults: A retrospective multicenter study. J. Pediatr. 2014;164:339–346. doi: 10.1016/j.jpeds.2013.09.032.
    1. Abend N.S., Topjian A.A., Gutierrez-Colina A.M., Donnelly M., Clancy R.R., Dlugos D.J. Impact of continuous EEG monitoring on clinical management in critically ill children. Neurocrit. Care. 2011;15:70–75. doi: 10.1007/s12028-010-9380-z.
    1. Abend N.S., Gutierrez-Colina A.M., Topjian A.A., Zhao H., Guo R., Donnelly M., Clancy R.R., Dlugos D.J. Nonconvulsive seizures are common in critically ill children. Neurology. 2011;76:1071–1077. doi: 10.1212/WNL.0b013e318211c19e.
    1. Kirkham F.J., Wade A.M., McElduff F., Boyd S.G., Tasker R.C., Edwards M., Neville B.G., Peshu N., Newton C.R. Seizures in 204 comatose children: Incidence and outcome. Intensive Care Med. 2012;38:853–862. doi: 10.1007/s00134-012-2529-9.
    1. Topjian A.A., Gutierrez-Colina A.M., Sanchez S.M., Berg R.A., Friess S.H., Dlugos D.J., Abend N.S. Electrographic status epilepticus is associated with mortality and worse short-term outcome in critically ill children. Crit. Care Med. 2013;41:215–223. doi: 10.1097/CCM.0b013e3182668035.
    1. Wagenman K.L., Blake T.P., Sanchez S.M., Schultheis M.T., Radcliffe J., Berg R.A., Dlugos D.J., Topjian A.A., Abend N.S. Electrographic status epilepticus and long-term outcome in critically ill children. Neurology. 2014;82:396–404. doi: 10.1212/WNL.0000000000000082.
    1. Payne E.T., Zhao X.Y., Frndova H., McBain K., Sharma R., Hutchison J.S., Hahn C.D. Seizure burden is independently associated with short term outcome in critically ill children. Brain. 2014;137:1429–1438. doi: 10.1093/brain/awu042.
    1. Sanchez S.M., Arndt D.H., Carpenter J.L., Chapman K.E., Cornett K.M., Dlugos D.J., Gallentine W.B., Giza C.C., Goldstein J.L., Hahn C.D., et al. Electroencephalography monitoring in critically ill children: Current practice and implications for future study design. Epilepsia. 2013;54:1419–1427. doi: 10.1111/epi.12261.
    1. Freilich E.R., Zelleke T., Gaillard W.D. Identification and evaluation of the child in status epilepticus. Semin. Pediatr. Neurol. 2010;17:144–149. doi: 10.1016/j.spen.2010.06.003.
    1. Gaillard W.D., Chiron C., Cross J.H., Harvey A.S., Kuzniecky R., Hertz-Pannier L., Vezina L.G. Guidelines for imaging infants and children with recent-onset epilepsy. Epilepsia. 2009;50:2147–2153. doi: 10.1111/j.1528-1167.2009.02075.x.
    1. Neligan A., Shorvon S.D. Frequency and prognosis of convulsive status epilepticus of different causes: A systematic review. Arch. Neurol. 2010;67:931–940. doi: 10.1001/archneurol.2010.169.
    1. Beckham J.D., Tyler K.L., IDSA Initial management of acute bacterial meningitis in adults: Summary of IDSA guidelines. Rev. Neurol. Dis. 2006;3:57–60.
    1. McGuire J.L., Greene A.M. Central nervous system infections. In: Abend N.S., Helfaer M., editors. Pediatric Neurocritical Care. Demos; New York, NY, USA: 2013. pp. 267–336.
    1. Spatola M., Novy J., Du Pasquier R., Dalmau J., Rossetti A.O. Status epilepticus of inflammatory etiology: A cohort study. Neurology. 2015;85:464–470. doi: 10.1212/WNL.0000000000001717.
    1. Davis R., Dalmau J. Autoimmunity, seizures, and status epilepticus. Epilepsia. 2013;54(Suppl. 6):46–49. doi: 10.1111/epi.12276.
    1. Florance N.R., Davis R.L., Lam C., Szperka C., Zhou L., Ahmad S., Campen C.J., Moss H., Peter N., Gleichman A.J., et al. Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann. Neurol. 2009;66:11–18. doi: 10.1002/ana.21756.
    1. Goldberg E.M., Taub K.S., Kessler S.K., Abend N.S. Anti-NMDA receptor encephalitis presenting with focal non-convulsive status epilepticus in a child. Neuropediatrics. 2011;42:188–190. doi: 10.1055/s-0031-1295408.
    1. Dravet C., Oguni H. Dravet syndrome (severe myoclonic epilepsy in infancy) Handb. Clin. Neurol. 2013;111:627–633.
    1. Le Gal F., Lebon S., Ramelli G.P., Datta A.N., Mercati D., Maier O., Combescure C., Rodriguez M.I., Seeck M., Roulet E., et al. When is a child with status epilepticus likely to have dravet syndrome? Epilepsy Res. 2014;108:740–747. doi: 10.1016/j.eplepsyres.2014.02.019.
    1. Tanabe T., Awaya Y., Matsuishi T., Iyoda K., Nagai T., Kurihara M., Yamamoto K., Minagawa K., Maekawa K. Management of and prophylaxis against status epilepticus in children with severe myoclonic epilepsy in infancy (SMEI; Dravet syndrome)—A nationwide questionnaire survey in Japan. Brain Dev. 2008;30:629–635. doi: 10.1016/j.braindev.2008.03.002.
    1. Wolf N.I., Rahman S., Schmitt B., Taanman J.W., Duncan A.J., Harting I., Wohlrab G., Ebinger F., Rating D., Bast T. Status epilepticus in children with Alpers’ disease caused by POLG1 mutations: EEG and MRI features. Epilepsia. 2009;50:1596–1607. doi: 10.1111/j.1528-1167.2008.01877.x.
    1. Gordon N. Alpers syndrome: Progressive neuronal degeneration of children with liver disease. Dev. Med. Child Neurol. 2006;48:1001–1003. doi: 10.1017/S0012162206002209.
    1. Lemke J.R., Riesch E., Scheurenbrand T., Schubach M., Wilhelm C., Steiner I., Hansen J., Courage C., Gallati S., Burki S., et al. Targeted next generation sequencing as a diagnostic tool in epileptic disorders. Epilepsia. 2012;53:1387–1398. doi: 10.1111/j.1528-1167.2012.03516.x.
    1. Chamberlain J.M., Okada P., Holsti M., Mahajan P., Brown K.M., Vance C., Gonzalez V., Lichenstein R., Stanley R., Brousseau D.C., et al. Lorazepam vs. diazepam for pediatric status epilepticus: A randomized clinical trial. JAMA. 2014;311:1652–1660. doi: 10.1001/jama.2014.2625.
    1. Chin R.F., Verhulst L., Neville B.G., Peters M.J., Scott R.C. Inappropriate emergency management of status epilepticus in children contributes to need for intensive care. J. Neurol. Neurosurg. Psychiatry. 2004;75:1584–1588. doi: 10.1136/jnnp.2003.032797.
    1. Yasiry Z., Shorvon S.D. The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: A meta-analysis of published studies. Seizure. 2014;23:167–174. doi: 10.1016/j.seizure.2013.12.007.
    1. Established Status Epilepticus Treatment Trial (ESETT) (Identifier NCT01960075) [(accessed on 17 February 2016)]; Available online: .
    1. Babl F.E., Sheriff N., Borland M., Acworth J., Neutze J., Krieser D., Ngo P., Schutz J., Thomson F., Cotterell E., et al. Emergency management of paediatric status epilepticus in Australia and New Zealand: Practice patterns in the context of clinical practice guidelines. J. Paediatr. Child Health. 2009;45:541–546. doi: 10.1111/j.1440-1754.2009.01536.x.
    1. Claassen J., Hirsch L.J., Mayer S.A. Treatment of status epilepticus: A survey of neurologists. J. Neurol. Sci. 2003;211:37–41. doi: 10.1016/S0022-510X(03)00036-4.
    1. Rogawski M.A., Loscher W. The neurobiology of antiepileptic drugs. Nat. Rev. Neurosci. 2004;5:553–564. doi: 10.1038/nrn1430.
    1. Trinka E. The use of valproate and new antiepileptic drugs in status epilepticus. Epilepsia. 2007;48(Suppl. 8):49–51. doi: 10.1111/j.1528-1167.2007.01349.x.
    1. Crepeau A.Z., Treiman D.M. Levetiracetam: A comprehensive review. Expert Rev. Neurother. 2010;10:159–171. doi: 10.1586/ern.10.3.
    1. Reiter P.D., Huff A.D., Knupp K.G., Valuck R.J. Intravenous levetiracetam in the management of acute seizures in children. Pediatr. Neurol. 2010;43:117–121. doi: 10.1016/j.pediatrneurol.2010.03.017.
    1. McTague A., Kneen R., Kumar R., Spinty S., Appleton R. Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: Experience from a children’s hospital. Seizure. 2012;21:529–534. doi: 10.1016/j.seizure.2012.05.010.
    1. Kirmani B.F., Crisp E.D., Kayani S., Rajab H. Role of intravenous levetiracetam in acute seizure management of children. Pediatr. Neurol. 2009;41:37–39. doi: 10.1016/j.pediatrneurol.2009.02.016.
    1. Gallentine W.B., Hunnicutt A.S., Husain A.M. Levetiracetam in children with refractory status epilepticus. Epilepsy Behav. 2009;14:215–218. doi: 10.1016/j.yebeh.2008.09.028.
    1. Abend N.S., Monk H.M., Licht D.J., Dlugos D.J. Intravenous levetiracetam in critically ill children with status epilepticus or acute repetitive seizures. Pediatr. Crit. Care Med. 2009;10:505–510. doi: 10.1097/PCC.0b013e3181a0e1cf.
    1. Brevoord J.C., Joosten K.F., Arts W.F., van Rooij R.W., de Hoog M. Status epilepticus: Clinical analysis of a treatment protocol based on midazolam and phenytoin. J. Child Neurol. 2005;20:476–481. doi: 10.1177/088307380502000602.
    1. Dunn D.W. Status epilepticus in children: Etiology, clinical features, and outcome. J. Child Neurol. 1988;3:167–173. doi: 10.1177/088307388800300303.
    1. Eriksson K.J., Koivikko M.J. Status epilepticus in children: Aetiology, treatment, and outcome. Dev. Med. Child Neurol. 1997;39:652–658. doi: 10.1111/j.1469-8749.1997.tb07358.x.
    1. Holtkamp M., Othman J., Buchheim K., Masuhr F., Schielke E., Meierkord H. A “malignant” variant of status epilepticus. Arch. Neurol. 2005;62:1428–1431. doi: 10.1001/archneur.62.9.1428.
    1. Shorvon S., Ferlisi M. The treatment of super-refractory status epilepticus: A critical review of available therapies and a clinical treatment protocol. Brain. 2011;134:2802–2818. doi: 10.1093/brain/awr215.
    1. Shorvon S. Super-refractory status epilepticus: An approach to therapy in this difficult clinical situation. Epilepsia. 2011;52(Suppl. 8):53–56. doi: 10.1111/j.1528-1167.2011.03238.x.
    1. Van Lierde I., van Paesschen W., Dupont P., Maes A., Sciot R. De novo cryptogenic refractory multifocal febrile status epilepticus in the young adult: A review of six cases. Acta Neurol. Belg. 2003;103:88–94.
    1. Wilder-Smith E.P., Lim E.C., Teoh H.L., Sharma V.K., Tan J.J., Chan B.P., Ong B.K. The NORSE (new-onset refractory status epilepticus) syndrome: Defining a disease entity. Ann. Acad. Med. Singap. 2005;34:417–420.
    1. Rathakrishnan R., Wilder-Smith E.P. New onset refractory status epilepticus (NORSE) J. Neurol. Sci. 2009;284:220–221. doi: 10.1016/j.jns.2009.03.023.
    1. Costello D.J., Kilbride R.D., Cole A.J. Cryptogenic new onset refractory status epilepticus (NORSE) in adults-infectious or not? J. Neurol. Sci. 2009;277:26–31. doi: 10.1016/j.jns.2008.10.007.
    1. Kramer U., Chi C.S., Lin K.L., Specchio N., Sahin M., Olson H., Nabbout R., Kluger G., Lin J.J., van Baalen A. Febrile infection-related epilepsy syndrome (FIRES): Pathogenesis, treatment, and outcome: A multicenter study on 77 children. Epilepsia. 2011;52:1956–1965. doi: 10.1111/j.1528-1167.2011.03250.x.
    1. Kramer U., Shorer Z., Ben-Zeev B., Lerman-Sagie T., Goldberg-Stern H., Lahat E. Severe refractory status epilepticus owing to presumed encephalitis. J. Child Neurol. 2005;20:184–187. doi: 10.1177/08830738050200030301.
    1. Van Baalen A., Hausler M., Boor R., Rohr A., Sperner J., Kurlemann G., Panzer A., Stephani U., Kluger G. Febrile infection-related epilepsy syndrome (FIRES): A nonencephalitic encephalopathy in childhood. Epilepsia. 2010;51:1323–1328. doi: 10.1111/j.1528-1167.2010.02535.x.
    1. Ismail F.Y., Kossoff E.H. AERRPS, DESC, NORSE, FIRES: Multi-labeling or distinct epileptic entities? Epilepsia. 2011;52:e185–e189. doi: 10.1111/j.1528-1167.2011.03293.x.
    1. Abend N.S., Dlugos D.J. Treatment of refractory status epilepticus: Literature review and a proposed protocol. Pediatr. Neurol. 2008;38:377–390. doi: 10.1016/j.pediatrneurol.2008.01.001.
    1. Owens J. Medical management of refractory status epilepticus. Semin. Pediatr. Neurol. 2010;17:176–181. doi: 10.1016/j.spen.2010.06.006.
    1. Wheless J.W. Treatment of refractory convulsive status epilepticus in children: Other therapies. Semin. Pediatr. Neurol. 2010;17:190–194. doi: 10.1016/j.spen.2010.06.007.
    1. Wilkes R., Tasker R.C. Pediatric intensive care treatment of uncontrolled status epilepticus. Crit. Care Clin. 2013;29:239–257. doi: 10.1016/j.ccc.2012.11.007.
    1. Riviello J.J., Jr., Claassen J., LaRoche S.M., Sperling M.R., Alldredge B., Bleck T.P., Glauser T., Shutter L., Treiman D.M., Vespa P.M., et al. Treatment of status epilepticus: An international survey of experts. Neurocrit. Care. 2013;18:193–200. doi: 10.1007/s12028-012-9790-1.
    1. Wilkes R., Tasker R.C. Intensive care treatment of uncontrolled status epilepticus in children: Systematic literature search of midazolam and anesthetic therapies. Pediatr. Crit. Care Med. 2014;15:632–639. doi: 10.1097/PCC.0000000000000173.
    1. Kim S.J., Lee D.Y., Kim J.S. Neurologic outcomes of pediatric epileptic patients with pentobarbital coma. Pediatr. Neurol. 2001;25:217–220. doi: 10.1016/S0887-8994(01)00311-3.
    1. Morrison G., Gibbons E., Whitehouse W.P. High-dose midazolam therapy for refractory status epilepticus in children. Intensive Care Med. 2006;32:2070–2076. doi: 10.1007/s00134-006-0362-8.
    1. Singhi S., Murthy A., Singhi P., Jayashree M. Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus. J. Child Neurol. 2002;17:106–110. doi: 10.1177/088307380201700203.
    1. Koul R., Chacko A., Javed H., Al Riyami K. Eight-year study of childhood status epilepticus: Midazolam infusion in management and outcome. J. Child Neurol. 2002;17:908–910. doi: 10.1177/08830738020170123002.
    1. Akyildiz B.N., Kumandas S. Treatment of pediatric refractory status epilepticus with topiramate. Childs Nerv. Syst. 2011;27:1425–1430. doi: 10.1007/s00381-011-1432-y.
    1. Lin J.J., Lin K.L., Wang H.S., Hsia S.H., Wu C.T. Effect of topiramate, in combination with lidocaine, and phenobarbital, in acute encephalitis with refractory repetitive partial seizures. Brain Dev. 2009;31:605–611. doi: 10.1016/j.braindev.2008.09.010.
    1. Kahriman M., Minecan D., Kutluay E., Selwa L., Beydoun A. Efficacy of topiramate in children with refractory status epilepticus. Epilepsia. 2003;44:1353–1356. doi: 10.1046/j.1528-1157.2003.11803.x.
    1. Perry M.S., Holt P.J., Sladky J.T. Topiramate loading for refractory status epilepticus in children. Epilepsia. 2006;47:1070–1071. doi: 10.1111/j.1528-1167.2006.00564.x.
    1. Blumkin L., Lerman-Sagie T., Houri T., Gilad E., Nissenkorn A., Ginsberg M., Watemberg N. Pediatric refractory partial status epilepticus responsive to topiramate. J. Child Neurol. 2005;20:239–241. doi: 10.1177/08830738050200031701.
    1. Stojanova V., Rossetti A.O. Oral topiramate as an add-on treatment for refractory status epilepticus. Acta Neurol. Scand. 2012;125:e7–e11. doi: 10.1111/j.1600-0404.2011.01562.x.
    1. Bragatti J.A., Torres C.M., Netto C.B., Vedolin L., Garzon E., Rieder C.R., Schwartz I.V., Bianchin M.M. Topiramate is effective for status epilepticus and seizure control in neuraminidase deficiency. Arq Neuropsiquiatr. 2011;69:565–566. doi: 10.1590/S0004-282X2011000400031.
    1. Grosso S., Zamponi N., Bartocci A., Cesaroni E., Cappanera S., Di Bartolo R., Balestri P. Lacosamide in children with refractory status epilepticus. A multicenter Italian experience. Eur. J. Paediatr. Neurol. 2014;18:604–608. doi: 10.1016/j.ejpn.2014.04.013.
    1. Jain V., Harvey A.S. Treatment of refractory tonic status epilepticus with intravenous lacosamide. Epilepsia. 2012;53:761–762. doi: 10.1111/j.1528-1167.2012.03419.x.
    1. Shiloh-Malawsky Y., Fan Z., Greenwood R., Tennison M. Successful treatment of childhood prolonged refractory status epilepticus with lacosamide. Seizure. 2011;20:586–588. doi: 10.1016/j.seizure.2011.03.005.
    1. Shaner D.M., McCurdy S.A., Herring M.O., Gabor A.J. Treatment of status epileticus: A prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin. Neurology. 1988;38:202–207. doi: 10.1212/WNL.38.2.202.
    1. Crawford T.O., Mitchell W.G., Fishman L.S., Snodgrass S.R. Very-high-dose phenobarbital for refractory status epilepticus in children. Neurology. 1988;38:1035–1040. doi: 10.1212/WNL.38.7.1035.
    1. Lee W.K., Liu K.T., Young B.W. Very-high-dose phenobarbital for childhood refractory status epilepticus. Pediatr. Neurol. 2006;34:63–65. doi: 10.1016/j.pediatrneurol.2005.06.014.
    1. Mirski M.A., Williams M.A., Hanley D.F. Prolonged pentobarbital and phenobarbital coma for refractory generalized status epilepticus. Crit. Care Med. 1995;23:400–404. doi: 10.1097/00003246-199502000-00028.
    1. Ilvento L., Rosati A., Marini C., L'Erario M., Mirabile L., Guerrini R. Ketamine in refractory convulsive status epilepticus in children avoids endotracheal intubation. Epilepsy Behav. 2015;49:343–346. doi: 10.1016/j.yebeh.2015.06.019.
    1. Rosati A., L’Erario M., Ilvento L., Cecchi C., Pisano T., Mirabile L., Guerrini R. Efficacy and safety of ketamine in refractory status epilepticus in children. Neurology. 2012;79:2355–2358. doi: 10.1212/WNL.0b013e318278b685.
    1. Mewasingh L.D., Sekhara T., Aeby A., Christiaens F.J., Dan B. Oral ketamine in paediatric non-convulsive status epilepticus. Seizure. 2003;12:483–489. doi: 10.1016/S1059-1311(03)00028-1.
    1. Gaspard N., Foreman B., Judd L.M., Brenton J.N., Nathan B.R., McCoy B.M., Al-Otaibi A., Kilbride R., Fernandez I.S., Mendoza L., et al. Intravenous ketamine for the treatment of refractory status epilepticus: A retrospective multicenter study. Epilepsia. 2013;54:1498–1503. doi: 10.1111/epi.12247.
    1. Sheth R.D., Gidal B.E. Refractory status epilepticus: Response to ketamine. Neurology. 1998;51:1765–1766. doi: 10.1212/WNL.51.6.1765.
    1. Yoshii A., Takeoka M., Kelly P.J., Krishnamoorthy K.S. Focal status epilepticus as atypical presentation of pyridoxine-dependent epilepsy. J. Child Neurol. 2005;20:696–698. doi: 10.1177/08830738050200081301.
    1. Goutieres F., Aicardi J. Atypical presentations of pyridoxine-dependent seizures: A treatable cause of intractable epilepsy in infants. Ann. Neurol. 1985;17:117–120. doi: 10.1002/ana.410170203.
    1. Chou M.L., Wang H.S., Hung P.C., Sun P.C., Huang S.C. Late-onset pyridoxine-dependent seizures: Report of two cases. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1995;36:434–437.
    1. Kluger G., Blank R., Paul K., Paschke E., Jansen E., Jakobs C., Worle H., Plecko B. Pyridoxine-dependent epilepsy: Normal outcome in a patient with late diagnosis after prolonged status epilepticus causing cortical blindness. Neuropediatrics. 2008;39:276–279. doi: 10.1055/s-0029-1202833.
    1. Russell K.E., Mulligan S.R., Mallory L.A. Diagnosis of pyridoxine-dependent seizures in a nineteen-year-old patient. Pediatr. Neurol. 2012;47:141–143. doi: 10.1016/j.pediatrneurol.2012.04.018.
    1. Valle-Morales L., Cortes-Cros E., Santana A., Barber M., Figueras T., Garcia-Hernandez J.A. Epileptic status refractory to conventional treatment caused by vitamin B6 deficiency. J Perinatol. 2009;29:252–253. doi: 10.1038/jp.2008.180.
    1. Broomall E., Natale J.E., Grimason M., Goldstein J., Smith C.M., Chang C., Kanes S., Rogawski M.A., Wainwright M.S. Pediatric super-refractory status epilepticus treated with allopregnanolone. Ann. Neurol. 2014;76:911–915. doi: 10.1002/ana.24295.
    1. Hattori H., Yamano T., Hayashi K., Osawa M., Kondo K., Aihara M., Haginoya K., Hamano S., Izumi T., Kaneko K., et al. Effectiveness of lidocaine infusion for status epilepticus in childhood: A retrospective multi-institutional study in Japan. Brain Dev. 2008;30:504–512. doi: 10.1016/j.braindev.2007.12.016.
    1. Hamano S., Sugiyama N., Yamashita S., Tanaka M., Hayakawa M., Minamitani M., Yoshinari S., Eto Y. Intravenous lidocaine for status epilepticus during childhood. Dev. Med. Child Neurol. 2006;48:220–222. doi: 10.1017/S0012162206000466.
    1. Zeiler F.A., Zeiler K.J., Teitelbaum J., Gillman L.M., West M., Kazina C.J. Lidocaine for status epilepticus in pediatrics. Can. J. Neurol. Sci. 2015;42:414–426. doi: 10.1017/cjn.2015.278.
    1. Nabbout R., Mazzuca M., Hubert P., Peudennier S., Allaire C., Flurin V., Aberastury M., Silva W., Dulac O. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES) Epilepsia. 2010;51:2033–2037. doi: 10.1111/j.1528-1167.2010.02703.x.
    1. Francois L.L., Manel V., Rousselle C., David M. Ketogenic regime as anti-epileptic treatment: Its use in 29 epileptic children. Arch. Pediatr. 2003;10:300–306.
    1. Cobo N.H., Sankar R., Murata K.K., Sewak S.L., Kezele M.A., Matsumoto J.H. The ketogenic diet as broad-spectrum treatment for super-refractory pediatric status epilepticus: Challenges in implementation in the pediatric and neonatal intensive care units. J. Child Neurol. 2015;30:259–266. doi: 10.1177/0883073813516192.
    1. Nam S.H., Lee B.L., Lee C.G., Yu H.J., Joo E.Y., Lee J., Lee M. The role of ketogenic diet in the treatment of refractory status epilepticus. Epilepsia. 2011;52:e181–e184. doi: 10.1111/j.1528-1167.2011.03289.x.
    1. Fung E.L., Chang S.K., Yam K.K., Yau P.Y. Ketogenic diet as a therapeutic option in super-refractory status epilepticus. Pediatr. Neonatol. 2015;56:429–431. doi: 10.1016/j.pedneo.2015.01.010.
    1. Sort R., Born A.P., Pedersen K.N., Fonsmark L., Uldall P. Ketogenic diet in 3 cases of childhood refractory status epilepticus. Eur. J. Paediatr. Neurol. 2013;17:531–536. doi: 10.1016/j.ejpn.2013.05.001.
    1. Kumada T., Miyajima T., Kimura N., Saito K., Shimomura H., Oda N., Fujii T. Modified Atkins diet for the treatment of nonconvulsive status epilepticus in children. J. Child Neurol. 2010;25:485–489. doi: 10.1177/0883073809347597.
    1. Guilliams K., Rosen M., Buttram S., Zempel J., Pineda J., Miller B., Shoykhet M. Hypothermia for pediatric refractory status epilepticus. Epilepsia. 2013;54:1586–1594. doi: 10.1111/epi.12331.
    1. Orlowski J.P., Erenberg G., Lueders H., Cruse R.P. Hypothermia and barbiturate coma for refractory status epilepticus. Crit. Care Med. 1984;12:367–372. doi: 10.1097/00003246-198404000-00006.
    1. Lin J.J., Lin K.L., Hsia S.H., Wang H.S. Therapeutic hypothermia for febrile infection-related epilepsy syndrome in two patients. Pediatr Neurol. 2012;47:448–450. doi: 10.1016/j.pediatrneurol.2012.08.013.
    1. Elting J.W., Naalt J.V., Fock J.M. Mild hypothermia for refractory focal status epilepticus in an infant with hemimegalencephaly. Eur. J. Paediatr. Neurol. 2010;14:452–455. doi: 10.1016/j.ejpn.2009.12.001.
    1. Shein S.L., Reynolds T.Q., Gedela S., Kochanek P.M., Bell M.J. Therapeutic hypothermia for refractory status epilepticus in a child with malignant migrating partial seizures of infancy and mutation: A case report. Ther. Hypoth. Temp. Manag. 2012;2:144–149. doi: 10.1089/ther.2012.0013.
    1. Robakis T.K., Hirsch L.J. Literature review, case report, and expert discussion of prolonged refractory status epilepticus. Neurocrit. Care. 2006;4:35–46. doi: 10.1385/NCC:4:1:035.
    1. Gedik A.H., Demirkol D., Tatli B., Bayraktar S., Alkan A., Karabocuoglu M., Yuksel A. Therapeutic plasma exchange for malignant refractory status epilepticus: A case report. Pediatr. Neurol. 2014;50:407–410. doi: 10.1016/j.pediatrneurol.2014.01.001.
    1. Ng Y.T., Kerrigan J.F., Rekate H.L. Neurosurgical treatment of status epilepticus. J. Neurosurg. 2006;105:378–381. doi: 10.3171/ped.2006.105.5.378.
    1. Alexopoulos A., Lachhwani D.K., Gupta A., Kotagal P., Harrison A.M., Bingaman W., Wyllie E. Resective surgery to treat refractory status epilepticus in children with focal epileptogenesis. Neurology. 2005;64:567–570. doi: 10.1212/01.WNL.0000150580.40019.63.
    1. Mohamed I.S., Otsubo H., Donner E., Ochi A., Sharma R., Drake J., Rutka J.T., Chuang S.H., Holowka S., Snead Iii O.C. Magnetoencephalography for surgical treatment of refractory status epilepticus. Acta Neurol. Scand. 2007;115:29–36. doi: 10.1111/j.1600-0404.2007.00807.x.
    1. Bhatia S., Ahmad F., Miller I., Ragheb J., Morrison G., Jayakar P., Duchowny M. Surgical treatment of refractory status epilepticus in children. J. Neurosurg. Pediatr. 2013;12:360–366. doi: 10.3171/2013.7.PEDS1388.
    1. Greiner H.M., Tillema J.M., Hallinan B.E., Holland K., Lee K.H., Crone K.R. Corpus callosotomy for treatment of pediatric refractory status epilepticus. Seizure. 2012;21:307–309. doi: 10.1016/j.seizure.2012.01.010.
    1. Ng Y.T., Kim H.L., Wheless J.W. Successful neurosurgical treatment of childhood complex partial status epilepticus with focal resection. Epilepsia. 2003;44:468–471. doi: 10.1046/j.1528-1157.2003.40302.x.
    1. Ma X., Liporace J., O’Connor M.J., Sperling M.R. Neurosurgical treatment of medically intractable status epilepticus. Epilepsy Res. 2001;46:33–38. doi: 10.1016/S0920-1211(01)00252-2.
    1. D’Giano C.H., Del C.G.M., Pomata H., Rabinowicz A.L. Treatment of refractory partial status epilepticus with multiple subpial transection: Case report. Seizure. 2001;10:382–385. doi: 10.1053/seiz.2001.0521.
    1. Duane D.C., Ng Y.T., Rekate H.L., Chung S., Bodensteiner J.B., Kerrigan J.F. Treatment of refractory status epilepticus with hemispherectomy. Epilepsia. 2004;45:1001–1004. doi: 10.1111/j.0013-9580.2004.60303.x.
    1. Lupashko S., Malik S., Donahue D., Hernandez A., Perry M.S. Palliative functional hemispherectomy for treatment of refractory status epilepticus associated with Alpers’ disease. Childs Nerv. Syst. 2011;27:1321–1323. doi: 10.1007/s00381-011-1495-9.
    1. Vossler D.G., Lee J.K., Ko T.S. Treatment of seizures in subcortical laminar heterotopia with corpus callosotomy and lamotrigine. J. Child Neurol. 1999;14:282–288. doi: 10.1177/088307389901400503.
    1. Winston K.R., Levisohn P., Miller B.R., Freeman J. Vagal nerve stimulation for status epilepticus. Pediatr. Neurosurg. 2001;34:190–192. doi: 10.1159/000056018.
    1. Griesemer D.A., Kellner C.H., Beale M.D., Smith G.M. Electroconvulsive therapy for treatment of intractable seizures. Initial findings in two children. Neurology. 1997;49:1389–1392. doi: 10.1212/WNL.49.5.1389.
    1. Incecik F., Horoz O.O., Herguner O.M., Yildizdas D., Altunbasak S. Electroconvulsive therapy for refractory status epilepticus in a child: A case report. Ann. Indian Acad. Neurol. 2015;18:364–365. doi: 10.4103/0972-2327.157250.
    1. Shin H.W., O’Donovan C.A., Boggs J.G., Grefe A., Harper A., Bell W.L., McCall W.V., Rosenquist P. Successful ECT treatment for medically refractory nonconvulsive status epilepticus in pediatric patient. Seizure. 2011;20:433–436. doi: 10.1016/j.seizure.2011.01.009.
    1. Tasker R.C., Vitali S.H. Continuous infusion, general anesthesia and other intensive care treatment for uncontrolled status epilepticus. Curr. Opin. Pediatr. 2014;26:682–689. doi: 10.1097/MOP.0000000000000149.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere